Takahito Wada Selected Research

ATR-X syndrome

10/2020	Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrins.
9/2020	5-Aminolevulinic acid can ameliorate language dysfunction of patients with ATR-X syndrome.
1/2018	Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome.
4/2009	[X-linked alpha-thalassemia/mental retardation syndrome].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takahito Wada Research Topics

Disease

4	ATR-X syndrome 10/2020 - 04/2009
4	Intellectual Disability (Idiocy) 01/2018 - 08/2014
3	Epilepsy (Aura) 01/2017 - 04/2011
2	Thalassemia 01/2016 - 03/2011
2	Schizencephaly 01/2015 - 01/2013
1	Transient Myeloproliferative Syndrome 04/2022
1	Down Syndrome (Down's Syndrome) 04/2022
1	Migraine Disorders (Migraine) 03/2022
1	Neoplasms (Cancer) 01/2022
1	Cognitive Dysfunction 10/2020
1	Hypophosphatasia 03/2020
1	alpha-Thalassemia 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	X-Linked Mental Retardation (Mental Retardation, X Linked) 01/2016
1	Myoclonic dystonia 04/2015
1	Movement Disorders (Movement Disorder) 04/2015
1	Myoclonus (Nocturnal Myoclonus) 04/2015
1	Drug Resistant Epilepsy 01/2015
1	Autistic Disorder (Autism) 01/2015
1	Sudden Death 01/2015
1	Muscle Hypotonia (Hypotonia) 01/2015
1	Seizures (Absence Seizure) 01/2015
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2015
1	Developmental Disabilities (Developmental Disability) 08/2014
1	Leukoencephalopathies 06/2014
1	Menkes Kinky Hair Syndrome (Menkes Disease) 04/2014
1	Type 2 Episodic Ataxia 01/2014
1	Glut1 Deficiency Syndrome 01/2014
1	Metabolic Brain Diseases (Encephalopathy, Metabolic) 01/2014
1	Episodic Ataxia 01/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2013
1	Transient Ischemic Attack 10/2013
1	MELAS Syndrome (Syndrome, MELAS) 10/2013
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2013
1	Atrophy 01/2013
1	Apnea 01/2013
1	Hemolytic Anemia 01/2013
1	Encephalitis (Encephalitis, Rasmussen) 01/2013
1	Focal Cortical Dysplasia 01/2013
1	Porencephaly 01/2013
1	Disease Progression 01/2013
1	Laryngomalacia 01/2013
1	Dyskinesias (Dyskinesia) 01/2013
1	Muscular Diseases (Myopathy) 01/2013
1	Polyneuropathies (Polyneuropathy) 09/2012
1	Deafness (Deaf Mutism) 05/2012
1	Liver Diseases (Liver Disease) 05/2012
1	Brain Neoplasms (Brain Tumor) 03/2012
1	Nonketotic Hyperglycinemia 01/2012
1	Human Influenza (Influenza) 01/2012
1	Brain Diseases (Brain Disorder) 01/2012
1	Hypothermia 01/2012
1	Headache (Headaches) 04/2011
1	Migraine with Aura (Familial Hemiplegic Migraine) 04/2011
1	Hemoglobinopathies 03/2011
1	Primary Ovarian Insufficiency 02/2011
1	Amenorrhea 02/2011
1	Uniparental Disomy 02/2006
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 02/2006

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2009
2	CreatineIBA 01/2017 - 01/2015
2	X-linked Creatine deficiencyIBA 01/2015 - 08/2014
2	Acetazolamide (Diamox)FDA LinkGeneric 01/2014 - 04/2011
2	Protons (Proton)IBA 10/2013 - 03/2012
1	Complementary DNA (cDNA)IBA 04/2022
1	Tryptamines (Triptans)IBA 03/2022
1	Pharmaceutical PreparationsIBA 03/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	PorphyrinsIBA 10/2020
1	AcidsIBA 09/2020
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 03/2020
1	Alkaline PhosphataseIBA 03/2020
1	ChromatinIBA 01/2016
1	Sarcoglycans (beta Sarcoglycan)IBA 04/2015
1	dimemorfan (AT 17)IBA 01/2015
1	CreatinineIBA 01/2015
1	Collagen Type IV (Type IV Collagen)IBA 01/2015
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 06/2014
1	TubulinIBA 06/2014
1	CopperIBA 04/2014
1	Copper Transport ProteinsIBA 04/2014
1	NucleotidesIBA 04/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2013
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2013
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Adenosine Triphosphate (ATP)IBA 05/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2012
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2012
1	EnzymesIBA 01/2012
1	GlobinsIBA 03/2011
1	GonadotropinsIBA 02/2011
1	X-linked Nuclear ProteinIBA 04/2009
1	Genetic Markers (Genetic Marker)IBA 02/2006
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2003

Therapy/Procedure

5	Therapeutics 01/2018 - 01/2012
1	Nephrectomy 01/2022
1	Oral Administration 10/2020